Record Information |
---|
Version | 2.0 |
---|
Created at | 2005-11-16 15:48:42 UTC |
---|
Updated at | 2024-09-03 04:18:42 UTC |
---|
NP-MRD ID | NP0000199 |
---|
Natural Product DOI | https://doi.org/10.57994/1481 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | 3-Methyl-2-oxovaleric acid |
---|
Description | 3-Methyl-2-oxovaleric acid is an abnormal metabolite that arises from the incomplete breakdown of branched-chain amino acids. 3-Methyl-2-oxovaleric acid is a neurotoxin, an acidogen, and a metabotoxin. A neurotoxin causes damage to nerve cells and nerve tissues. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of 3-methyl-2-oxovaleric acid are associated with maple syrup urine disease. MSUD is a metabolic disorder caused by a deficiency of the branched-chain alpha-keto acid dehydrogenase complex (BCKDC), leading to a buildup of the branched-chain amino acids (leucine, isoleucine, and valine) and their toxic by-products (ketoacids) in the blood and urine. The symptoms of MSUD often show in infancy and lead to severe brain damage if untreated. MSUD may also present later depending on the severity of the disease. If left untreated in older individuals, during times of metabolic crisis, symptoms of the condition include uncharacteristically inappropriate, extreme, or erratic behaviour and moods, hallucinations, anorexia, weight loss, anemia, diarrhea, vomiting, dehydration, lethargy, oscillating hypertonia and hypotonia, ataxia, seizures, hypoglycemia, ketoacidosis, opisthotonus, pancreatitis, rapid neurological decline, and coma. In maple syrup urine disease, the brain concentration of branched-chain ketoacids can increase 10- to 20-fold. This leads to a depletion of glutamate and a consequent reduction in the concentration of brain glutamine, aspartate, alanine, and other amino acids. The result is a compromise of energy metabolism because of a failure of the malate-aspartate shuttle and a diminished rate of protein synthesis (PMID: 15930465 ). 3-Methyl-2-oxovaleric acid is a keto-acid, which is a subclass of organic acids. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart, liver, and kidney abnormalities, seizures, coma, and possibly death. These are also the characteristic symptoms of untreated MSUD. Many affected children with organic acidemias experience intellectual disability or delayed development. |
---|
Structure | InChI=1S/C6H10O3/c1-3-4(2)5(7)6(8)9/h4H,3H2,1-2H3,(H,8,9) |
---|
Synonyms | Value | Source |
---|
2-oxo-3-Methyl-N-valeric acid | ChEBI | 2-oxo-3-Methylpentanoic acid | ChEBI | 2-oxo-3-Methylvalerate | ChEBI | 2-oxo-3-Methylvaleric acid | ChEBI | 2-Oxoisoleucine | ChEBI | 2-Oxokolavenic acid | ChEBI | 3-Ethyl-3-methylpyruvic acid | ChEBI | 3-Methyl-2-oxopentanoic acid | ChEBI | alpha-Keto-beta-methyl-N-valeric acid | ChEBI | alpha-Keto-beta-methylvaleric acid | ChEBI | alpha-oxo-beta-Methyl-N-valeric acid | ChEBI | alpha-oxo-beta-Methylvaleric acid | ChEBI | Ketoisoleucine | ChEBI | 2-oxo-3-Methyl-N-valerate | Generator | 2-oxo-3-Methylpentanoate | Generator | 2-Oxokolavenate | Generator | 3-Ethyl-3-methylpyruvate | Generator | 3-Methyl-2-oxopentanoate | Generator | a-Keto-b-methyl-N-valerate | Generator | a-Keto-b-methyl-N-valeric acid | Generator | alpha-Keto-beta-methyl-N-valerate | Generator | Α-keto-β-methyl-N-valerate | Generator | Α-keto-β-methyl-N-valeric acid | Generator | a-Keto-b-methylvalerate | Generator | a-Keto-b-methylvaleric acid | Generator | alpha-Keto-beta-methylvalerate | Generator | Α-keto-β-methylvalerate | Generator | Α-keto-β-methylvaleric acid | Generator | a-oxo-b-Methyl-N-valerate | Generator | a-oxo-b-Methyl-N-valeric acid | Generator | alpha-oxo-beta-Methyl-N-valerate | Generator | Α-oxo-β-methyl-N-valerate | Generator | Α-oxo-β-methyl-N-valeric acid | Generator | a-oxo-b-Methylvalerate | Generator | a-oxo-b-Methylvaleric acid | Generator | alpha-oxo-beta-Methylvalerate | Generator | Α-oxo-β-methylvalerate | Generator | Α-oxo-β-methylvaleric acid | Generator | 3-Methyl-2-oxovalerate | Generator | (3R)-3-Methyl-2-oxopentanoate | HMDB | (3R)-3-Methyl-2-oxopentanoic acid | HMDB | (R)-3-Methyl-2-oxopentanoate | HMDB | (R)-3-Methyl-2-oxopentanoic acid | HMDB | (S)-3-Methyl-2-oxopentanoate | HMDB | (S)-3-Methyl-2-oxopentanoic acid | HMDB | 2-keto-3-Methylvalerate | HMDB | 2-keto-3-Methylvaleric acid | HMDB, MeSH | 3-Methyl-2-oxo-pentanoate | HMDB | 3-Methyl-2-oxo-pentanoic acid | HMDB | 3-Methyl-2-oxo-valerate | HMDB | 3-Methyl-2-oxo-valeric acid | HMDB | 3-Methyl-2-oxovaleric | HMDB | 2-keto Methylvalerate | MeSH, HMDB | KMVA | MeSH, HMDB | alpha-keto-beta-Methylvaleric acid, calcium salt, (S)-isomer | MeSH, HMDB | alpha-keto-beta-Methylvaleric acid, monosodium salt, (S)-isomer | MeSH, HMDB | alpha-keto-beta-Methylvaleric acid, (S)-isomer | MeSH, HMDB | alpha-keto-beta-Methylvaleric acid, calcium salt | MeSH, HMDB | alpha-keto-beta-Methylvaleric acid, sodium salt, (+-)-isomer | MeSH, HMDB | alpha-keto-beta-Methylvaleric acid, (+-)-isomer | MeSH, HMDB | alpha-keto-beta-Methylvaleric acid, sodium salt | MeSH, HMDB |
|
---|
Chemical Formula | C6H10O3 |
---|
Average Mass | 130.1418 Da |
---|
Monoisotopic Mass | 130.06299 Da |
---|
IUPAC Name | 3-methyl-2-oxopentanoic acid |
---|
Traditional Name | 3-methyl-2-oxopentanoic acid |
---|
CAS Registry Number | 1460-34-0 |
---|
SMILES | CCC(C)C(=O)C(O)=O |
---|
InChI Identifier | InChI=1S/C6H10O3/c1-3-4(2)5(7)6(8)9/h4H,3H2,1-2H3,(H,8,9) |
---|
InChI Key | JVQYSWDUAOAHFM-UHFFFAOYSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
HMBC NMR | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2023-12-21 | View Spectrum | HSQC NMR | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2023-12-21 | View Spectrum | COSY NMR | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2023-12-21 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, CD3OD, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2023-12-21 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2023-12-21 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Species Where Detected | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as short-chain keto acids and derivatives. These are keto acids with an alkyl chain the contains less than 6 carbon atoms. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Keto acids and derivatives |
---|
Sub Class | Short-chain keto acids and derivatives |
---|
Direct Parent | Short-chain keto acids and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Branched fatty acid
- Methyl-branched fatty acid
- Short-chain keto acid
- Alpha-keto acid
- Fatty acyl
- Alpha-hydroxy ketone
- Ketone
- Carboxylic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Carbonyl group
- Hydrocarbon derivative
- Organic oxygen compound
- Organooxygen compound
- Organic oxide
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | |
---|
Predicted Properties | |
---|
General References | - Wendel U, Even G, Langenbeck U, Schadewaldt P, Hummel W: Determination of (S)- and (R)-2-oxo-3-methylvaleric acid in plasma of patients with maple syrup urine disease. Clin Chim Acta. 1992 Jun 15;208(1-2):85-91. [PubMed:1638756 ]
- Przyrembel H, Bremer HJ, Duran M, Bruinvis L, Ketting D, Wadman SK, Baumgartner R, Irle U, Bachmann C: Propionyl-CoA carboxylase deficiency with overflow of metabolites of isoleucine catabolism at all levels. Eur J Pediatr. 1979 Jan 18;130(1):1-14. [PubMed:759179 ]
|
---|